Haverford Trust Co Invests $629,000 in Cigna Group $CI

23 Aug 2026, 13:44 by Tristan Rich · The Markets Daily

Haverford Trust Co purchased a new position in Cigna Group (NYSE:CI – Free Report) during the 2nd quarter, HoldingsChannel.com reports. The fund purchased 2,282 shares of the health services provider’s stock, valued at approximately $629,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Wilkerson Advisory Group LLC purchased a new stake in Cigna Group during the 4th quarter worth approximately $25,000. Cedar Mountain Advisors LLC boosted its stake in shares of Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after buying an additional 68 shares during the last quarter. Johnson Financial Group Inc. purchased a new position in shares of Cigna Group during the 2nd quarter valued at approximately $29,000. Kemnay Advisory Services Inc. acquired a new stake in shares of Cigna Group during the fourth quarter worth approximately $29,000. Finally, Prosperity Bancshares Inc bought a new stake in shares of Cigna Group in the fourth quarter worth $29,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Activity

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Nicole S. Jones sold 2,677 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the transaction, the insider directly owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This trade represents a 9.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 23,012 shares of company stock worth $6,386,550. 0.60% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of research firms have commented on CI. Morgan Stanley increased their price objective on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research note on Wednesday, May 20th. The Goldman Sachs Group boosted their target price on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Royal Bank Of Canada upped their target price on shares of Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research note on Friday, May 1st. Mizuho increased their price target on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Finally, Raymond James Financial downgraded Cigna Group from a “strong-buy” rating to an “outperform” rating and decreased their price target for the stock from $350.00 to $320.00 in a research note on Monday, August 3rd. Fifteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $339.45.

Check Out Our Latest Stock Analysis on Cigna Group

Cigna Group Stock Performance

Cigna Group stock opened at $276.19 on Friday. The company has a market cap of $72.98 billion, a PE ratio of 11.43, a P/E/G ratio of 0.95 and a beta of 0.29. The company has a fifty day moving average price of $284.20 and a two-hundred day moving average price of $281.38. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a 12 month low of $239.51 and a 12 month high of $315.47.

Cigna Group (NYSE:CI – Get Free Report) last issued its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. The company had revenue of $70.04 billion for the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm’s revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the company earned $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Research analysts expect that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s dividend payout ratio is currently 25.82%.

Cigna Group Company Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.